Clinical Trial Update: Efficacy Study of Temsirolimus to Treat Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating temsirolimus for head and neck squamous cell carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Torisel (Temsirolimus)

Snippet

Sponsor: Hannover Medical School | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED